PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.430
-0.150 (-3.28%)
At close: Apr 28, 2026, 4:00 PM EDT
4.610
+0.180 (4.06%)
After-hours: Apr 28, 2026, 4:18 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $84.54 million as of April 28, 2026. Its market cap has increased by 238.59% in one year.
Market Cap
84.54M
Enterprise Value
72.88M
1-Year Change
238.59%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $84.54M, an increase of 2.55%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 87.40M | 21.06% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 87.56M |
| eXoZymes | 87.55M |
| Rani Therapeutics Holdings | 86.64M |
| Pelthos Therapeutics | 83.79M |
| Q32 Bio | 83.68M |
| Sangamo Therapeutics | 83.27M |
| OKYO Pharma | 82.92M |
| Adicet Bio | 82.45M |